Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Commonly used along with long-acting insulin. Rapid-acting 15 min 1 hour 2 to 4 hours Taken with meals, typically right before a meal. Commonly used along with longer-acting insulin. Rapid-acting ...

Prescriptions for insulin glargine-yfgn (Semglee) rapidly increased when its status switched from a standard biosimilar to ...

If you have type 1 diabetes, you'll still need to take long-acting insulin, too, to help control your blood sugar. This depends on whether you have insurance and the type of plan you have.

NPH insulin has a less steady effect than newer types of long-acting insulin, and may carry more risk of low blood sugar. It can still be an effective component of diabetes care, and is generally ...

Long-acting therapies offer value for chronic disease, improving adherence and outcomes. This OHE report highlights HTA gaps, ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin degludec) got US approval late last year. [caption id ...

once per day adults who are already using insulin Usually, your starting dose of Tresiba will be the same as the total unit dose of the intermediate- or long-acting insulin that you currently use.